BACKGROUND: Recently, klotho has been proposed as a link between cardiovascular diseases and premature aging, but the relationship between KLOTHO genes and cardiovascular risk factors, especially glucose metabolism, in humans is unclear. OBJECTIVES: We investigate the relationship between polymorphisms G395A in promoter and C1818T in exon 4 of the KLOTHO gene with glucose metabolism and cardiovascular risk factors in Korean women. MATERIAL AND METHODS: In 251 women (mean age 51.3+/-6.9 yr), body mass index (BMI), waist circumference, blood pressure, fasting plasma glucose, insulin and lipid profiles were measured. The genotyping of polymorphisms G395A in promoter and C1818T in exon 4 of the KLOTHO gene was performed by allelic discrimination using a 5' nuclease polymerase chain reaction assay. RESULTS: Allele frequencies of G395A polymorphism was 0.829 for the G allele and 0.171 for the A allele and allele frequencies of C1818T polymorphism were 0.804 for the C allele and 0.196 for the T allele, both of which were in compliance with Hardy-Weinberg equilibrium and the two polymorphisms were in linkage disequilibrium (D'=0.43, p<0.01). Mean systolic blood pressure was significantly higher in A allele carriers of G395A polymorphism compared with non-carriers, and the significance was persistent even after adjustment for age and BMI. Mean fasting plasma glucose was significantly higher in T allele carriers of C1818T polymorphism compared with non-carriers, and the significance was persistent even after adjustment for age and BMI. Subjects without any minor allele from either single nucleotide polymorphisms (SNP) had significantly lower mean values for systolic, diastolic blood pressure and fasting plasma glucose levels compared with subjects with both minor allele from either SNP. CONCLUSIONS: We observed that KLOTHO G395A polymorphism was associated with blood pressure and KLOTHO C1818T polymorphism was associated with glucose metabolism in Korean women. Further studies are needed to clarify this relationship.
BACKGROUND: Recently, klotho has been proposed as a link between cardiovascular diseases and premature aging, but the relationship between KLOTHO genes and cardiovascular risk factors, especially glucose metabolism, in humans is unclear. OBJECTIVES: We investigate the relationship between polymorphisms G395A in promoter and C1818T in exon 4 of the KLOTHO gene with glucose metabolism and cardiovascular risk factors in Korean women. MATERIAL AND METHODS: In 251 women (mean age 51.3+/-6.9 yr), body mass index (BMI), waist circumference, blood pressure, fasting plasma glucose, insulin and lipid profiles were measured. The genotyping of polymorphisms G395A in promoter and C1818T in exon 4 of the KLOTHO gene was performed by allelic discrimination using a 5' nuclease polymerase chain reaction assay. RESULTS: Allele frequencies of G395A polymorphism was 0.829 for the G allele and 0.171 for the A allele and allele frequencies of C1818T polymorphism were 0.804 for the C allele and 0.196 for the T allele, both of which were in compliance with Hardy-Weinberg equilibrium and the two polymorphisms were in linkage disequilibrium (D'=0.43, p<0.01). Mean systolic blood pressure was significantly higher in A allele carriers of G395A polymorphism compared with non-carriers, and the significance was persistent even after adjustment for age and BMI. Mean fasting plasma glucose was significantly higher in T allele carriers of C1818T polymorphism compared with non-carriers, and the significance was persistent even after adjustment for age and BMI. Subjects without any minor allele from either single nucleotide polymorphisms (SNP) had significantly lower mean values for systolic, diastolic blood pressure and fasting plasma glucose levels compared with subjects with both minor allele from either SNP. CONCLUSIONS: We observed that KLOTHOG395A polymorphism was associated with blood pressure and KLOTHOC1818T polymorphism was associated with glucose metabolism in Korean women. Further studies are needed to clarify this relationship.
Authors: M Kuro-o; Y Matsumura; H Aizawa; H Kawaguchi; T Suga; T Utsugi; Y Ohyama; M Kurabayashi; T Kaname; E Kume; H Iwasaki; A Iida; T Shiraki-Iida; S Nishikawa; R Nagai; Y I Nabeshima Journal: Nature Date: 1997-11-06 Impact factor: 49.962
Authors: Dan E Arking; Alice Krebsova; Milan Macek; Milan Macek; Albert Arking; I Saira Mian; Linda Fried; Ada Hamosh; Srabani Dey; Iain McIntosh; Harry C Dietz Journal: Proc Natl Acad Sci U S A Date: 2002-01-15 Impact factor: 11.205
Authors: H Aizawa; Y Saito; T Nakamura; M Inoue; T Imanari; Y Ohyama; Y Matsumura; H Masuda; S Oba; N Mise; K Kimura; A Hasegawa; M Kurabayashi; M Kuro-o; Y Nabeshima; R Nagai Journal: Biochem Biophys Res Commun Date: 1998-08-28 Impact factor: 3.575
Authors: Dan E Arking; Diane M Becker; Lisa R Yanek; Daniele Fallin; Daniel P Judge; Taryn F Moy; Lewis C Becker; Harry C Dietz Journal: Am J Hum Genet Date: 2003-03-31 Impact factor: 11.025
Authors: T Utsugi; T Ohno; Y Ohyama; T Uchiyama; Y Saito; Y Matsumura; H Aizawa; H Itoh; M Kurabayashi; S Kawazu; S Tomono; Y Oka; T Suga; M Kuro-o; Y Nabeshima; R Nagai Journal: Metabolism Date: 2000-09 Impact factor: 8.694
Authors: J M Peacock; D K Arnett; L D Atwood; R H Myers; H Coon; S S Rich; M A Province; G Heiss Journal: Arterioscler Thromb Vasc Biol Date: 2001-11 Impact factor: 8.311
Authors: M Kuro-o; K Hanaoka; Y Hiroi; T Noguchi; Y Fujimori; S Takewaki; M Hayasaka; H Katoh; A Miyagishi; R Nagai Journal: Circ Res Date: 1995-01 Impact factor: 17.367
Authors: Gwendalyn D King; CiDi Chen; Mickey M Huang; Ella Zeldich; Patricia L Brazee; Eli R Schuman; Maxime Robin; Gregory D Cuny; Marcie A Glicksman; Carmela R Abraham Journal: Biochem J Date: 2012-01-01 Impact factor: 3.857
Authors: Eman A Elghoroury; Fatina I Fadel; Manal F Elshamaa; Dina Kandil; Doaa M Salah; Marwa M El-Sonbaty; Hebatallah Farouk; Mona Raafat; Soha Nasr Journal: Pediatr Nephrol Date: 2018-01-08 Impact factor: 3.714